Study guide

Section 6.4: Eating, Substance Use, and Personality Disorders

NCCPA PANCE Physician Assistant Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular System

1.1 Hypertension (Essential & Secondary) 1.2 Coronary Artery Disease & Myocardial Infarction 1.3 Heart Failure & Cardiomyopathy 1.4 Cardiac Arrhythmias & Conduction Disorders 1.5 Valvular Heart Disease 1.6 Vascular Diseases (Aortic Aneurysm, PAD, DVT) 1.7 Congenital Heart Disease (ASD, VSD, PDA, Coarctation, Tetralogy of Fallot)

2 Chapter 2: Pulmonary System

Section 2.1: Asthma & Bronchospastic Disease Section 2.2: Chronic Obstructive Pulmonary Disease (COPD) Section 2.3: Infectious Pulmonary Disorders (Pneumonia & Tuberculosis) Section 2.4: Restrictive, Vascular & Neoplastic Pulmonary Conditions

3 Chapter 3: Gastrointestinal/Nutrition

3.1 Esophageal & Gastric Disorders (GERD, PUD) 3.2 Hepatic, Biliary & Pancreatic Disorders 3.3 Small & Large Bowel Disorders (IBD, Diverticulitis, Obstruction) 3.4 Colorectal Neoplasms & Nutritional Deficiencies

4 Chapter 4: Musculoskeletal System

Section 4.1: Rheumatologic & Autoimmune MSK Conditions (RA, Lupus, Gout, OA) Section 4.2: Infectious & Inflammatory MSK Disorders (Osteomyelitis, Septic Arthritis) Section 4.3: Bone & Joint Disorders (Fractures, Osteoporosis, Fibromyalgia) Section 4.4: Spine and Soft Tissue Pathology (Low Back Pain, Tendonitis)

5 Chapter 5: Neurologic System

Section 5.1: Cerebrovascular Disease (Stroke, TIA) Section 5.2: Seizure Disorders & Epilepsy Section 5.3: Demyelinating & Neurodegenerative Diseases Section 5.4: Headache Syndromes & Cranial Nerve Disorders

6 Chapter 6: Psychiatry/Behavioral Science

Section 6.1: Depressive and Bipolar Disorders Section 6.2: Anxiety, Trauma-Related, and Obsessive-Compulsive Disorders Section 6.3: Schizophrenia and Psychotic Disorders Section 6.4: Eating, Substance Use, and Personality Disorders

7 Chapter 7: Infectious Diseases

7.1 Viral Infections (HIV, EBV, Influenza) 7.2 Bacterial & Spirochetal Infections (Sepsis, Meningitis) 7.3 Fungal & Parasitic Infections 7.4 Tick-Borne Diseases (Lyme, Rocky Mountain Spotted Fever)

8 Chapter 8: Reproductive System

8.1 Obstetrics: Normal Pregnancy & Prenatal Care 8.2 Obstetrics: Pregnancy Complications 8.3 Gynecology: Menstruation, Menopause, PCOS, and Vaginal Infections

9 Chapter 9: Endocrine System

Section 9.1: Diabetes Mellitus & Acute Complications Section 9.2: Thyroid Disorders & Goiter Section 9.3: Adrenal & Pituitary Disorders

10 Chapter 10: Eyes, Ears, Nose, and Throat

Section 10.1: Ophthalmic Disorders (Glaucoma, Conjunctivitis, Cataracts) Section 10.2: Otic Disorders (Otitis Media/Externa, Vertigo, Labyrinthitis) Section 10.3: Nose, Sinus, and Throat Complaints (Sinusitis, Pharyngitis, Epiglottitis)

11 Chapter 11: Professional Practice

11.1 Bioethics & Legal Standards (Informed Consent, Autonomy, HIPAA) 11.2 Patient Safety, Quality Improvement, and Communication 11.3 Evidence-Based Medicine & Clinical Practice Guidelines

12 Chapter 12: Hematologic System

Section 12.1: Anemias (Microcytic, Macrocytic, Hemolytic/Sickle Cell) Section 12.2: Coagulation and Bleeding Disorders (ITP, TTP, Hemophilia, vWD) Section 12.3: Hematologic Malignancies (Leukemia, Lymphoma, Multiple Myeloma)

13 Chapter 13: Renal System

13.1 Acute Kidney Injury (AKI) & Chronic Kidney Disease (CKD) 13.2 Acid-Base and Electrolyte Disorders 13.3 Glomerular & Tubulointerstitial Diseases

14 Chapter 14: Dermatologic System

Section 14.1: Inflammatory & Autoimmune Skin Conditions Section 14.2: Infectious Skin Conditions Section 14.3: Skin Neoplasms & Burn Management

15 Chapter 15: Genitourinary System

Section 15.1: Male Genitourinary Disorders (BPH, Prostate Cancer, Testicular Torsion, ED) Section 15.2: Urinary Incontinence, Nephrolithiasis, and GU Trauma

Section 6.4: Eating, Substance Use, and Personality Disorders

Key Takeaways Explain This Topic AI

Anorexia Nervosa is distinguished from Bulimia Nervosa by a low BMI (<18.5 kg/m²), whereas Bulimia patients have normal or elevated BMI.

Refeeding syndrome is a life-threatening complication of rapid refeeding characterized by severe hypophosphatemia.

Delirium Tremens (DT) occurs 48-96 hours after alcohol cessation, presenting with delirium and severe autonomic instability; treat with benzodiazepines.

Opioid overdose presents with pinpoint pupils and respiratory depression, treated with naloxone; withdrawal is highly distressing but not life-threatening.

Personality disorders are divided into Cluster A (odd/eccentric), Cluster B (dramatic/erratic), and Cluster C (anxious/fearful).

Last updated: July 2026

Why Eating, Substance Use, and Personality Disorders Matter for the PANCE

This section covers a diverse array of high-yield psychiatric conditions: eating disorders, substance use disorders, and personality disorders. The PANCE focus is highly practical, testing the ability to distinguish Anorexia Nervosa from Bulimia Nervosa based on body mass index (BMI) thresholds and clinical signs, recognizing and managing life-threatening alcohol withdrawal states (Delirium Tremens) and opioid crises, and identifying the characteristic features of the ten personality disorders grouped into Clusters A, B, and C.

Eating Disorders: Anorexia Nervosa vs. Bulimia Nervosa

Distinguishing between these two disorders on the PANCE is primarily based on Body Mass Index (BMI) .

Anorexia Nervosa

Core Feature : Restriction of energy intake leading to a significantly low body weight (BMI < 18.5 kg/m²) , accompanied by an intense fear of gaining weight and a distorted perception of body shape or weight.

Subtypes :

Restricting type : Weight loss is achieved through dieting, fasting, and/or excessive exercise.

Binge-eating/purging type : The individual engages in episodes of binge eating followed by self-induced vomiting, or misuse of laxatives, diuretics, or enemas.

Clinical Presentation : Lanugo (fine, downy hair), bradycardia, hypotension, hypothermia, dry skin, osteopenia, amenorrhea, peripheral edema. Purging behaviors can lead to Russell's sign (calluses or scars on the knuckles from contact with incisors during vomiting) and parotid gland hypertrophy ('chipmunk cheeks').

Electrolytes : Hypokalemia, hypochloremic metabolic alkalosis (due to loss of stomach acid from vomiting), hypomagnesemia, and elevated BUN (dehydration).

Management :

First-line : Nutritional rehabilitation (target weight gain of 1-2 lbs/week for outpatients) and psychotherapy (Family-Based Therapy is first-line for adolescents; CBT for adults).

Hospitalization criteria : Heart rate < 40 bpm, blood pressure < 80/50 mmHg, temperature < 97°F (36.1°C), electrolyte abnormalities, or BMI < 15 kg/m².

Refeeding Syndrome : A life-threatening complication of rapid refeeding in severely malnourished patients. The introduction of carbohydrates causes an insulin surge, leading to intracellular shifts of electrolytes. Characterized by hypophosphatemia (the hallmark), hypokalemia, hypomagnesemia, and fluid overload, leading to cardiac arrhythmias and delirium.

Pharmacotherapy : SSRIs (olanzapine can be used to promote weight gain and address obsessive thoughts about food). Bupropion is strictly contraindicated in all patients with eating disorders due to an increased risk of seizures.

Bulimia Nervosa

Core Feature : Recurrent episodes of binge eating (eating an abnormally large amount of food with a sense of lack of control) followed by inappropriate compensatory behaviors (vomiting, laxatives, fasting, excessive exercise) to prevent weight gain.

Weight Status : Patients with Bulimia Nervosa maintain a normal or overweight BMI (≥ 18.5 kg/m²) . This is the key distinguishing factor from purging-type anorexia.

Clinical Presentation : Parotid gland hypertrophy, dental enamel erosion (perimylolysis, especially on lingual surfaces), Russell's sign, and subconjunctival hemorrhages (from the pressure of vomiting).

Electrolytes : Hypokalemia, hypochloremic metabolic alkalosis.

Management :

Psychotherapy : CBT is the most effective first-line treatment.

Pharmacotherapy : Fluoxetine is the only FDA-approved medication for bulimia and is effective at a high dose (60 mg/day) to reduce binge-purge cycles. Bupropion is contraindicated due to seizure risk.

  • Substance Use Disorders: Alcohol and Opioids
  • Alcohol Withdrawal

Alcohol acts as a central nervous system depressant by enhancing GABA (inhibitory) activity and inhibiting NMDA glutamate (excitatory) receptors. Abrupt cessation leads to a loss of GABA inhibition and a surge in NMDA excitation.

Clinical Timeline of Alcohol Withdrawal

Mild Withdrawal (6 to 36 hours): Tremors, anxiety, headache, palpitations, diaphoresis, gastrointestinal upset, normal mental status.

Withdrawal Seizures (12 to 48 hours): Generalized tonic-clonic seizures, often occurring as a single event or brief flurry.

Alcoholic Hallucinosis (12 to 48 hours): Visual, auditory, or tactile hallucinations. Crucially, the patient's sensorium is intact (they are oriented to time, place, and person).

Delirium Tremens (DT) (48 to 96 hours): A medical emergency characterized by delirium (altered sensorium/disorientation) , severe autonomic instability (hyperthermia, tachycardia, marked hypertension, diaphoresis), psychomotor agitation, and vivid hallucinations. Mortality is up to 5% if untreated.

Management of Alcohol Withdrawal

Benzodiazepines : First-line therapy to prevent seizures and delirium. Dosing is guided by the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) protocol. Long-acting agents (e.g., chlordiazepoxide, diazepam) are preferred due to smoother self-tapering.

Hepatic Impairment Exception : In patients with advanced liver disease (common in chronic alcoholics), use the 'LOT' benzodiazepines ( Lorazepam, Oxazepam, Temazepam ) because they undergo direct glucuronidation and do not accumulate active metabolites.

Thiamine (Vitamin B1) : Must be administered before or concurrently with glucose/dextrose-containing IV fluids to prevent precipitating Wernicke-Korsakoff syndrome (triad of encephalopathy, oculomotor dysfunction, and ataxia).

  • Opioid Overdose and Withdrawal
  • Opioid Overdose

Presentation : The classic triad of altered mental status (coma) , respiratory depression (respiratory rate < 8-10 breaths/min), and pinpoint pupils (miosis) . Other signs include bradycardia, hypotension, and hypothermia.

Management : Secure the airway and assist ventilation. Administer Naloxone , a rapid-acting mu-opioid receptor antagonist. Dosing should be titrated to restore adequate ventilation, not necessarily to full consciousness, to avoid precipitating acute, severe withdrawal.

Opioid Withdrawal

Presentation : While highly distressing and painful, opioid withdrawal is not life-threatening (unlike alcohol or benzodiazepine withdrawal). Symptoms include mydriasis (dilated pupils) , lacrimation, rhinorrhea, piloerection ('goosebumps'), yawning, diaphoresis, severe myalgias, abdominal cramps, nausea, vomiting, and diarrhea.

Management :

Symptomatic : Clonidine (alpha-2 agonist) to treat autonomic symptoms (hypertension, sweating); loperamide for diarrhea; antiemetics; NSAIDs for muscle pain.

Replacement Therapy : Methadone (long-acting agonist) or Buprenorphine (partial agonist, often combined with naloxone).

Personality Disorders

Personality disorders are characterized by enduring, maladaptive patterns of behavior and inner experience that deviate markedly from cultural expectations. They are grouped into three clusters:

Cluster A ('Weird' - Odd or Eccentric)

Paranoid : Pervasive distrust and suspiciousness of others, interpreting motives as malevolent.

Schizoid : Voluntary social isolation. Disinterested in close relationships (including family), prefers solitary activities, flat affect, emotionally cold.

Schizotypal : Odd, eccentric behavior and speech, magical thinking (e.g., belief in clairvoyance or telepathy), unusual perceptual experiences, ideas of reference, and severe social anxiety.

Cluster B ('Wild' - Dramatic, Emotional, or Erratic)

Antisocial : Disregard for and violation of the rights of others, deceitfulness, impulsivity, lack of remorse. Patient must be at least 18 years old for diagnosis, with evidence of Conduct Disorder before age 15.

Borderline : Instability of interpersonal relationships, self-image, and affect. Characterized by marked impulsivity, frantic efforts to avoid abandonment, suicidal behavior or self-mutilation, chronic feelings of emptiness, and splitting (defense mechanism where others are viewed as all good or all bad). Treatment of choice is Dialectical Behavior Therapy (DBT) .

Histrionic : Pervasive attention-seeking behavior, shallow and rapidly shifting emotions, dramatic or theatrical presentation, and use of physical appearance/seduction to draw attention.

Narcissistic : Grandiosity, lack of empathy, need for admiration, sense of entitlement, and exploitation of others for personal gain.

Cluster C ('Worry' - Anxious or Fearful)

Avoidant : Extreme social inhibition, feelings of inadequacy, and hypersensitivity to criticism. Unlike schizoid patients, avoidant individuals desire social interaction but avoid it out of an intense fear of rejection or embarrassment.

Dependent : Pervasive, excessive need to be taken care of, leading to submissive, clinging behaviors and difficulty making everyday decisions without reassurance.

Obsessive-Compulsive Personality Disorder (OCPD) : Preoccupation with orderliness, perfectionism, and mental and interpersonal control at the expense of flexibility and efficiency. Unlike OCD, OCPD traits are ego-syntonic ; the patient does not perceive their rigid behaviors as problematic.

  • Personality Disorder Key Feature Behavioral Mnemonic / Cluster Treatment of Choice
  • Schizoid Social detachment, content alone 'Aloof' / Cluster A Psychotherapy
  • Avoidant Fear of rejection, wants friends 'Cowardly' / Cluster C CBT

Borderline Splitting, self-harm, unstable relationships 'Unstable' / Cluster B Dialectical Behavior Therapy (DBT)

  • Antisocial Criminality, lack of remorse, ages ≥18 'Rule-breaker' / Cluster B Psychotherapy / Behavioral
  • OCPD Perfectionist, control-freak 'Rigid' / Cluster C Psychotherapy / CBT
  • Neurodevelopmental Disorders: Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD is a neurodevelopmental disorder on the PANCE Psychiatry/Behavioral Science blueprint, characterized by inattention, hyperactivity, and impulsivity that begins in childhood and persists into adulthood in many patients.

Diagnostic Criteria (DSM-5): Symptoms must be present before age 12 , persist for at least 6 months, and occur in two or more settings (e.g., home and school/work). At least 6 inattention or 6 hyperactive-impulsive symptoms are required for children (5 for adults ≥17 years).

Presentation Subtypes: Predominantly inattentive, predominantly hyperactive-impulsive, or combined.

Management:

Behavioral therapy — first-line for preschool-aged children (under 6 years).

Stimulant medications — first-line pharmacotherapy for school-aged children and adults. Examples: methylphenidate, amphetamine salts. Mechanism: increase dopamine and norepinephrine in the synaptic cleft.

Non-stimulant alternatives: Atomoxetine (SNRI — slower onset, useful with comorbid anxiety or substance use history), Guanfacine/Clonidine (alpha-2 agonists — useful for tics or sleep disturbance).

*### Autism Spectrum Disorder (ASD)

ASD is a neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction, plus restricted, repetitive patterns of behavior, interests, or activities. Symptoms must be present in early developmental period.

Core Deficits: (1) Deficits in social-emotional reciprocity, nonverbal communication, and relationships; (2) Restricted/repetitive behaviors, insistence on sameness, restricted interests, or sensory hypersensitivity/hyposensitivity.

Screening: AAP recommends universal autism-specific screening at 18 and 24 months (M-CHAT-R).

Management: Early intensive behavioral intervention (Applied Behavior Analysis — ABA), speech and language therapy, occupational therapy, and educational support. Risperidone and aripiprazole are FDA-approved for irritability/aggression associated with ASD. There is no medication that treats the core social-communication deficits.

PANCE Pearl: Severity is graded Level 1 (requiring support), Level 2 (requiring substantial support), and Level 3 (requiring very substantial support).

PANCE Traps: *

* Stimulant Side Effects: Insomnia, appetite suppression, growth velocity slowdown, increased blood pressure and heart rate. Schedule II controlled substances due to abuse potential — avoid in patients with active substance use disorder or cardiac arrhythmia/conduction defects.

* Atomoxetine Black Box Warning: Carries an FDA black box warning for suicidal ideation in children and adolescents — monitor mood closely when initiating.

* Cardiac Screening: Sudden death risk in patients with pre-existing structural cardiac abnormalities — obtain a careful cardiac history before initiating stimulants; routine ECG is not required in asymptomatic patients without cardiac history.

Classic PANCE Traps & Clinical Pearls

The Eating Disorder Seizure Trap : Antidepressant therapy is common in eating disorders. However, Bupropion is strictly contraindicated in patients with anorexia or bulimia due to a high risk of drug-induced seizures, which are precipitated by electrolyte shifts.

Russell's Sign vs. Weight Status : Do not assume that Russell's sign (knuckle calluses) automatically means Bulimia Nervosa. A purging anorexic patient will also have Russell's sign. The diagnosis is determined by BMI (Anorexia BMI < 18.5; Bulimia BMI ≥ 18.5).

Alcohol Withdrawal: Intact Sensorium : If a patient is experiencing visual hallucinations but is fully oriented to person, place, and time, the diagnosis is Alcoholic Hallucinosis , not Delirium Tremens. Delirium Tremens requires delirium (altered sensorium/disorientation) .

Wernicke's: Thiamine First : When treating an intoxicated or malnourishing patient in withdrawal, always administer Thiamine before Glucose to prevent Wernicke's encephalopathy, as glucose infusion increases thiamine demand, depleting residual brain thiamine stores.